Natera Inc at JPMorgan Healthcare Conference Transcript
Okay. We're going to go ahead and get started. I'm Tycho Peterson from the Life Science team. It's my pleasure to introduce our next company this morning, Natera. We'll do a breakout right after in the Olympic Room. And with that, let me turn it over to Steve Chapman.
Great. Thank you, Tycho. So we really had a fantastic 2019, which was my first year as CEO. I think I presented here at the conference probably a week into the job last year. So I want to first talk about some of the strong performance and key milestones that we achieved right at the tail end of last year that have set us up for a very successful and strong 2020.
So first, I'm pleased to announce we processed roughly 800,000 tests in 2019, which accounts for roughly 20% growth through 2018. And we had a very strong Q4 2019, which actually from a quarter-on-quarter standpoint, the growth between Q3 and 4 was stronger this year than it even was in 2018
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
